Neurescue Aps
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Neurescue Aps - overview
Established
2013
Location
Copenhagen, -, Denmark
Primary Industry
Medical Devices & Equipment
About
Based in Copenhagen, Denmark, and founded in 2013 by CEO Habib Frost and Bjorn Broby Glavind, Neurescue Aps, a. k. a. Neurescue operates as a medical device company focused on advancing the treatment of cardiac arrest, the leading cause of death worldwide.
In February 2024, Neurescue Aps raised DKK 50 million in a Series A funding led by West Hill Capital. In addition, Neurescue Aps also raised venture funding from Nina Capital. The company's flagship product, the Neurescue device, is an intelligent fluoroscopy-free aortic balloon catheter, designed to enhance patient outcomes during life-threatening emergencies. The Neurescue device works by inflating a balloon in the descending aorta via a femoral artery introducer sheath.
The company plans to use its proceeds from February 2024 funding to expand its business in the emergency medical device market.
Current Investors
SEED Capital, GreenOcean Capital, West Hill Capital
Primary Industry
Medical Devices & Equipment
Sub Industries
Cardiology, Monitoring Equipment, Therapeutic Devices
Website
www.neurescue.com
Verticals
HealthTech, Manufacturing
Company Stage
Series A
Total Amount Raised
Subscriber access only
Neurescue Aps - financials
| Fiscal Year Ended | Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | Apr 22, 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | - | - | - | - | - | - | - | - | - | - | - | - |
| % Revenue Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA (USD) | (1,041,347) | (2,628,908) | (3,387,673) | (13,486,329) | (14,929,027) | (14,270,863) | (11,295,279) | (8,065,433) | (9,200,110) | - | - | - |
| Operating Income (USD) | (1,041,347) | (2,628,908) | (3,387,673) | (13,486,329) | (14,929,027) | (14,270,863) | (11,295,279) | (8,065,433) | (9,201,954) | - | - | - |
| Operating Margin | - | - | - | - | - | - | - | - | - | - | - | - |
| % EBITDA Margin | - | - | - | - | - | - | - | - | - | - | - | - |
| NET Income (USD) | (920,375) | (2,160,041) | (3,040,812) | (11,067,229) | (12,504,250) | (11,927,784) | (9,703,089) | (7,435,209) | (7,804,639) | - | - | - |
| % Net Margin | - | - | - | - | - | - | - | - | - | - | - | - |
Neurescue Aps - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.